**HEADLINE: TRUMPRX: THE $200B BRAND THAT DOESN'T SELL PILLS—IT SELLS VETOES**

HEADLINE: TRUMPRX: THE $200B BRAND THAT DOESN’T SELL PILLS—IT SELLS VETOES

One-Liner: TrumpRX isn’t a pharma company. It’s a political loyalty platform disguised as a prescription benefit card—and it’s already changing the math for Medicare.

The Tactic: Patients sign up for “free” drug discounts. In exchange, they auto-enroll in a political action fund that runs attack ads against any lawmaker who votes to cap drug prices below Trump’s polling floor.

The Impact: Within 90 days, two swing-state senators flipped their votes on price controls. TrumpRX now holds covenants on 14% of U.S. prescription volume—without owning a single lab.

CEO Takeaway: This isn’t disruption. It’s a hostage negotiation. If your supply chain touches consumer health, you now have a third stakeholder at the table: a brand that doesn’t care about margins—only mandates.